From Medtronic

The CoreValve system, designed to replace a diseased aortic valve without open-heart surgery or surgical removal of the native valve, has now been implanted in more than 10,000 patients worldwide in 32 countries outside the US. Typically delivered through the femoral artery, CoreValve is used in 75% of transarterial transcatheter valve replacement procedures. Recent clinical data has demonstrated positive long-term performance and durability.


Which Medical Device of the Year 2011

Runner-up: Cardiology (Jointly awarded with the SAPIEN Transcatheter Heart Valve)

"The judges couldn’t decide between these two devices, which have both stood 'the test of time'. The medium term (five years) performance of both valves is sufficiently robust to hope that TAVI may well become the first preferred option in patients with aortic stenosis." - Dr Azfar Zaman, Senior Editor for Cardiology. Read more



Have you used this device?

Your opinion matters to others - rate this device or add a comment

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.